USFDA, MHRA and Lachman Consultants - All Under One Roof at CPhI's 3rd Annual Global Pharma Regulatory Summit 2014
The summit focuses on the new and updated guidelines introduced by the prominent regulatory bodies around the globe. Top regulators including Dr Sumit sen, USFDA, Dr Anjana Agarwal, Senior Assessor, MHRA, Fran Zipp, President, Lachman Consultants & Brijesh Patel, Ex-MHRA will address and resolve the concerns from the regulatory perspective.
Some of the important topics being discussed at this regulatory summit include analytical methodologies on reducing and controlling metallic & elemental impurities refuse to receive guidelines, regulatory and procedural guidelines to support the implementation of variations guidelines. Visit http://www.pharmaregulation-india.com/pr for more information on the topics and a complete list of speakers.
The summit has already attracted more than 120 delegates from companies like Cipla, Sun Pharma, Dr Reddy's Laboratories, Piramal Enterprises, Glenmark Generics, Jubilant Life sciences, GlaxoSmithKline Asia, Zydus Cadila, USV and many more.
About UBM India:
UBM India is India's leading live media and events company that engages people and enriches businesses. We at UBM India provide the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content-led conferences & seminars, tech media, live events, data services and powerful media brands. UBM India hosts over 20 large-scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc and is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organiser in mainland China, India and Malaysia. For further details, please visit http://www.ubmindia.in
Contact: Suvidha Shetty, [email protected], +91-(0)22-6172-7001
